OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
June 21, 2018
The contract development and manufacturing company has received an additional approval from Health Canada to manufacture monoclonal antibody drug substance at its first plant in Icheon, South Korea.
June 19, 2018
WuXi STA supported the development of hepatitis drug through marketing authorization holder pilot program.
June 14, 2018
Recipharm adds inhalation drug manufacturing capacity with the acquisition of Sanofi’s Holmes Chapel, UK site.
June 13, 2018
Cambrex expands its generic API research and development capabilities at its Milan, Italy site.
June 07, 2018
Vetter anounced the Open Innovation Challenge to examine the applicability of digital trends to injection systems.
June 06, 2018
Under the contract, AMRI will focus on the development and manufacture of APIs and drug product for Phase I clinical studies.
June 02, 2018
Open communication channels between all the parties involved is key when outsourcing analytical methods, says Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
New and expanded facilities point to the continuing growth of the biopharmaceutical industry.
June 01, 2018
Madison Dearborn Partners will acquire a majority ownership position in CDMO Alcami.
Catalent’s GPEx technology was used to develop antibody for anti-methamphetamine clinical study.